Patent · US Expired

Substituted 5,11-dihydro-6H-dibenz[b,e]azepin-6-ones and pharmaceutical compositions containing same

US4567178A · kind A · utility

21Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 7, 1985
Grant dateJan 28, 1986
Priority date
Expiry dateJan 7, 2005

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to novel substituted 5,11-dihydro-6H-dibenz[b,e]azepin-6-one of the formula ##STR1## wherein A represents a (1-methyl-4-piperidinyl)-acetyl, (4-methyl-1-piperazinyl)-acetyl, or [(1-methyl-4-piperidinyl)-amino]-carbonyl group, and the acid addition salts thereof, which have valuable pharmacological properties, particularly an ulcer-inhibiting and secretion-inhibiting activity. The compounds of Formula I may be prepared using methods conventionally used for analogous compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.